Can You Go Directly from 40 mg to 80 mg of Strattera?
Yes, you can increase directly from 40 mg to 80 mg of atomoxetine (Strattera) after a minimum of 3 days at the 40 mg dose, as this is the FDA-approved dosing schedule for patients over 70 kg body weight and adults. 111
FDA-Approved Titration Schedule
The official FDA labeling provides clear guidance on dose escalation:
- For patients over 70 kg and adults: Start at 40 mg total daily dose, then increase after a minimum of 3 days to the target dose of 80 mg 111
- No intermediate dosing step is required or recommended between 40 mg and 80 mg
- The 80 mg dose can be taken as a single morning dose or split into two divided doses (morning and late afternoon/evening) 1
Important Timing Considerations
Wait at least 3 days at 40 mg before increasing to 80 mg. This minimum waiting period allows for:
- Initial tolerability assessment
- Reduction of gastrointestinal side effects that are more common with rapid dose escalation 2
Why 80 mg is the Target Dose
The 80 mg dose is specifically designated as the target therapeutic dose for adults and adolescents over 70 kg 11. Research demonstrates that:
- Effect sizes increase substantially when patients reach and maintain the 80 mg target dose 3
- Real-world data show many patients are underdosed at approximately 60 mg/day, which may compromise treatment outcomes 4
- Patients should remain at 80 mg for 4-6 weeks before judging efficacy, as atomoxetine's effect size continues to increase over time (reaching 0.82 effect size in the 80 mg group by 6 months) 3
Common Pitfall to Avoid
The most critical error is increasing the dose too rapidly, which significantly increases gastrointestinal side effects (particularly nausea) and initial somnolence 2. However, the FDA-approved 3-day minimum interval from 40 mg to 80 mg is designed to balance tolerability with achieving therapeutic dosing.
Further Dose Adjustments
If you don't achieve optimal response after 2-4 additional weeks at 80 mg, the dose may be increased to a maximum of 100 mg 11. However, there is no evidence supporting increased effectiveness at doses higher than the standard target 1.
Special Circumstances Requiring Different Dosing
You would need intermediate dosing or slower titration only if you: